Finance

Beta
Lists
4565:TYO
Nxera Pharma Co Ltd
956,00 JPY
-2,75%
(-27,00) 1D
15 ივნ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4565...
Open
979 JPY
High
988 JPY
Low
948 JPY
Mkt. cap
88,53 მლრდ.
Avg. vol.
1,12 მლნ.
Volume
715,60 ათ.
52-wk high
1 247 JPY
52-wk low
723 JPY
EPS
-110 JPY
Shares outstanding
76,30 მლნ.
No. of employees
354
Open
979 JPY
High
988 JPY
Low
948 JPY
Mkt. cap
88,53 მლრდ.
Avg. vol.
1,12 მლნ.
Volume
715,60 ათ.
52-wk high
1 247 JPY
52-wk low
723 JPY
EPS
-110 JPY
Shares outstanding
76,30 მლნ.
No. of employees
354
News stories
From sources across the web
About Nxera Pharma Co Ltd
CEO-
Employees354
Founded22 ივნ. 1990
Headquarters-
SectorPharmaceutical industry
Websitenxera.life
Last report
1 მაი. 2026
Fiscal period
Q1 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
11,26 მლრდ. / -
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
8,45 მლრდ.
6,75 მლრდ.
7,77 მლრდ.
11,26 მლრდ.
Cost of goods sold
1,86 მლრდ.
2,67 მლრდ.
2,05 მლრდ.
1,12 მლრდ.
Cost of revenue
1,86 მლრდ.
2,67 მლრდ.
2,05 მლრდ.
1,12 მლრდ.
Research and development expenses
3,67 მლრდ.
3,73 მლრდ.
3,27 მლრდ.
3,03 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,86 მლრდ.
3,84 მლრდ.
363,00 მლნ.
3,57 მლრდ.
Operating expense
7,16 მლრდ.
7,23 მლრდ.
8,08 მლრდ.
6,89 მლრდ.
Total operating expenses
9,01 მლრდ.
9,90 მლრდ.
10,13 მლრდ.
8,01 მლრდ.
Operating income
-563,00 მლნ.
-3,15 მლრდ.
-2,36 მლრდ.
3,24 მლრდ.
Other non operating income
-
-
-5,02 მლრდ.
-2,00 მლნ.
EBT including unusual items
-1,57 მლრდ.
-3,12 მლრდ.
-8,11 მლრდ.
3,04 მლრდ.
EBT excluding unusual items
-1,57 მლრდ.
-3,12 მლრდ.
-6,30 მლრდ.
3,04 მლრდ.
Income tax expense
811,00 მლნ.
-1,44 მლრდ.
-391,00 მლნ.
1,25 მლრდ.
Effective tax rate
-51,79%
46,34%
4,82%
41,08%
Other operating expenses
-376,00 მლნ.
-338,00 მლნ.
996,00 მლნ.
295,00 მლნ.
Net income
-2,38 მლრდ.
-1,67 მლრდ.
-7,72 მლრდ.
1,79 მლრდ.
Net profit margin
-28,13%
-24,76%
-99,41%
15,93%
Earnings per share
-
-
-
-
Interest and investment income
255,00 მლნ.
239,00 მლნ.
1,06 მლრდ.
144,00 მლნ.
Interest expense
-1,26 მლრდ.
-204,00 მლნ.
-
-287,00 მლნ.
Net interest expenses
-1,00 მლრდ.
35,00 მლნ.
1,06 მლრდ.
-143,00 მლნ.
Depreciation and amortization charges
-
-
3,45 მლრდ.
-
EBITDA
532,00 მლნ.
-2,04 მლრდ.
-1,28 მლრდ.
4,35 მლრდ.
Gain or loss from assets sale
-
-
1,16 მლრდ.
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer